View Author
patient stress imaging perfusion dobutamine dobutamine stress echocardiography segment heart artery disease study myocardium echocardiography disease artery viability perfusion imaging spect value dysfunctional prognostic value prognostic cardiol tissue contractile reserve death hibernating diabetes event article exercise dysfunctional segments target heart rate contractile heart failure hibernating myocardium failure infarction follow-up tomography revascularisation analysis result testing score defect dysfunction model uptake emission dobutamine-atropine stress revascularization image prevalence positron emission tomography function table perfusion scintigraphy systolic dose dobutamine infusion region motion downloaded perfusion defect agreement group swets subscription service improvement prognostic information dobutamine stress test ejection fraction heart failure symptoms predictor dobutamine-atropine doppler hypotension non-viable number safety elhendy nonfatal
10 Most Recent Publications
|
Improved control of severe hypoglycemia in patients with malignant insulinomas by peptide receptor radionuclide therapy
(Article)
Schaik, E. van Vliet, E.I. van Herder, W.W. de Feelders, R.A. Krenning, E.P. Khan, S. Kamp, K. Valkema, R. Nederveen, F.H. van Teunissen, J.J.M. Kwekkeboom, D.J. |
2011-11-01
|
|
Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours
(Article)
Teunissen, J.J.M. Kwekkeboom, D.J. Valkema, R. Krenning, E.P. |
2011-10-01
|
|
Brain perfusion patterns in familial frontotemporal lobar degeneration
(Article)
Seelaar, H. Papma, J.M. Garraux, G. Koning, I. de Reijs, A.E.M. Valkema, R. Rozemuller, A.J.M. Salmon, E. Swieten, J.C. van |
2011-07-26
|
|
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy:
86Y or
90Y imaging?
(Article)
Walrand, S. Flux, G. Konijnenberg, M. Valkema, R. Krenning, E.P. Lhommel, R. Pauwels, S. Jamar, F. |
2011-05-01
|
|
Dynamic and static small-animal SPECT in rats for monitoring renal function after177Lu-labeled Tyr3-octreotate radionuclide therapy
(Article)
Melis, M.L. Swart, J. de Visser, M. de Berndsen, S.C. Koelewijn, S. Valkema, R. Boerman, O.C. Krenning, E.P. Jong, M. de |
2010-12-01
|
|
Molecular imaging of inflammation and intraplaque vasa vasorum: A step forward to identification of vulnerable plaques?
(Article)
Kate, G.L. ten Sijbrands, E.J.G. Valkema, R. Cate, F.J. ten Feinstein, S.B. Steen, A.F.W. van der Daemen, M.J. Schinkel, A.F. |
2010-10-01
|
|
Preclinical and Clinical Studies of Peptide Receptor Radionuclide Therapy
(Article)
Pool, S.E. Krenning, E.P. Koning, G.A. Eijck, C.H.J. van Teunissen, J.J.M. Kam, B.L. Valkema, R. Kwekkeboom, D. Jong, M. de |
2010-05-01
|
|
Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues
(Article)
Rolleman, E.J. Melis, M.L. Valkema, R. Boerman, O.C. Krenning, E.P. Jong, M. de |
2010-05-01
|
|
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
(Article)
Kwekkeboom, D.J. Kam, B.L. Essen, M. van Teunissen, J.J.M. Eijck, C.H.J. van Valkema, R. Jong, M. de Herder, W.W. de Krenning, E.P. |
2010-03-01
|
|
Peptide-receptor radionuclide therapy for endocrine tumors
(Article)
Essen, M. van Krenning, E.P. Kam, B.L. Jong, M. de Valkema, R. Kwekkeboom, D. |
2009-07-01
|
